TMPRSS-ERG fusion gene expression is highly prevalent in patients with prostate cancer.19 We have previously shown that a prometastatic gene CXCR420 and an androgen biosynthetic enzyme AKR1C321 are downstream-regulated genes of TMPRSS2-ERG fusions in prostate cancer cells. This evidence concerns the gene ERG and prostate cancer.